相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardioprotective Properties of HDL: Structural and Functional Considerations
Eleni Pappa et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation
Yasaman Shokri et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
Carlo Cervellati et al.
ATHEROSCLEROSIS (2019)
Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease
Chrysan J. Mohammed et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
Atena Variji et al.
ATHEROSCLEROSIS (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
Guisong Wang et al.
PLOS ONE (2018)
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis An Observational Cohort Study
Alexander V. Sorokin et al.
CIRCULATION RESEARCH (2018)
The Changing Face of HDL and the Best Way to Measure It
Sotirios K. Karathanasis et al.
CLINICAL CHEMISTRY (2017)
Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men
Jianghua Wen et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
Gender-and lesion number-dependent difference in atherogenic index of plasma in Chinese people with coronary heart disease
Wei Ni et al.
SCIENTIFIC REPORTS (2017)
Time to ditch HOL-C as a measure of PINION HOL function?
Graziella E. Ronsein et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
Setor K. Kunutsor et al.
ATHEROSCLEROSIS (2016)
Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance
Alena Viktorinova et al.
CLINICAL BIOCHEMISTRY (2016)
The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes
Mehryar Zargari et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
High-density lipoprotein and inflammation in cardiovascular disease
Margery A. Connelly et al.
TRANSLATIONAL RESEARCH (2016)
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
Wijtske Annema et al.
TRANSLATIONAL RESEARCH (2016)
Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme
Abdolkarim Mahrooz
CURRENT CLINICAL PHARMACOLOGY (2016)
Arterial stiffness and coronary artery disease
Ignatios Ikonomidis et al.
CURRENT OPINION IN CARDIOLOGY (2015)
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Susan Kuhnast et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease
Adelheid Kratzer et al.
CARDIOVASCULAR RESEARCH (2014)
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: The role of activity-determined PON1 192Q/R phenotypes
Abdolkarim Mahrooz et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery
Tomasz Zapolski
MEDICAL SCIENCE MONITOR (2014)
Translation of High-Density Lipoprotein Function Into Clinical Practice Current Prospects and Future Challenges
Robert S. Rosenson et al.
CIRCULATION (2013)
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1
Se Won Kim et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk
W. H. Wilson Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Association of uric acid with mortality in patients with stable coronary artery disease
Gjin Ndrepepa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients
Naoto Katakami et al.
ATHEROSCLEROSIS (2011)
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
Michel P. Hermans et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
Milada Dobiasova et al.
JOURNAL OF LIPID RESEARCH (2011)
Age- and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings Results From the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 Patients Without Known Coronary Artery Disease
James K. Min et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Reducing residual vascular risk in patients with atherogenic dyslipidemia: where do we go from here?
Michel P. Hermans et al.
CLINICAL LIPIDOLOGY (2010)
Atherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events
Altan Onat et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis
Makiko Tamada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study
Tomonori Okamura et al.
ATHEROSCLEROSIS (2009)
The HDL proteome: a marker-and perhaps mediator-of coronary artery disease
Jay W. Heinecke
JOURNAL OF LIPID RESEARCH (2009)
Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma
Philip W. Connelly et al.
JOURNAL OF LIPID RESEARCH (2008)
Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers
N Johnston et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris
J Cosin-Sales et al.
EUROPEAN HEART JOURNAL (2005)
Effect of chronic total coronary occlusion on treatment strategy
RD Christofferson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Relationship between serum lipoprotein ratios and insulin resistance in obesity
A Brehm et al.
CLINICAL CHEMISTRY (2004)
分享论文
